Cargando…

Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer

This study is to investigate the optimal treatment option for synchronous bilateral breast cancer (SBBC) by comparing dosimetric and radiobiological parameters of intensity‐modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) plans using single and dual isocenters. Twenty patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Sang‐Won, Kang, Seonghee, Lee, Boram, Song, Changhoon, Eom, Keun‐Yong, Jang, Bum‐Sup, Kim, In Ah, Kim, Jae‐Sung, Cho, Woong, Shin, Dong‐Suk, Kim, Jin‐Young, Chung, Jin‐Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359036/
https://www.ncbi.nlm.nih.gov/pubmed/35727562
http://dx.doi.org/10.1002/acm2.13706
_version_ 1784764054807511040
author Kang, Sang‐Won
Kang, Seonghee
Lee, Boram
Song, Changhoon
Eom, Keun‐Yong
Jang, Bum‐Sup
Kim, In Ah
Kim, Jae‐Sung
Cho, Woong
Shin, Dong‐Suk
Kim, Jin‐Young
Chung, Jin‐Beom
author_facet Kang, Sang‐Won
Kang, Seonghee
Lee, Boram
Song, Changhoon
Eom, Keun‐Yong
Jang, Bum‐Sup
Kim, In Ah
Kim, Jae‐Sung
Cho, Woong
Shin, Dong‐Suk
Kim, Jin‐Young
Chung, Jin‐Beom
author_sort Kang, Sang‐Won
collection PubMed
description This study is to investigate the optimal treatment option for synchronous bilateral breast cancer (SBBC) by comparing dosimetric and radiobiological parameters of intensity‐modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) plans using single and dual isocenters. Twenty patients with SBBC without lymph node involvement were selected retrospectively. Four treatment plans were generated for each patient using the Eclipse treatment planning system (Varian Medical System, Palo Alto, CA, USA) following two delivery techniques with two isocenter conditions—IMRT using a single isocenter (IMRT_Iso1), VMAT using a single isocenter (VMAT_Iso1), IMRT using dual isocenters (IMRT_Iso2), and VMAT using dual isocenters (VMAT_Iso2). A dose of 42.56 Gy in 16 fractions was prescribed for the planning target volume (PTV). All plans were calculated using the Acuros XB algorithm and a photon optimizer for a 6‐MV beam of a Vital Beam linear accelerator. PTV‐related dosimetric parameters were analyzed. Further, the homogeneity index, conformity index, and conformation number were computed to evaluate plan quality. Dosimetric parameters were also measured for the organs at risk (OARs). In addition, the equivalent uniform dose corresponding to an equivalent dose related to a reference of 2 Gy per fraction, the tumor control probability, and the normal tissue complication probability were calculated based on the dose–volume histogram to investigate the radiobiological impact on PTV and OARs. IMRT_Iso1 exhibited similar target coverage and a certain degree of dosimetric improvement in OAR sparing compared to the other techniques. It also exhibited some radiobiological improvement, albeit insignificant. Although IMRT_Iso1 significantly increased monitor unit compared to VMAT_Iso1, which is the best option in terms of delivery efficiency, there was only a 22% increase in delivery time. Therefore, in conclusion, IMRT_Iso1, the complete treatment of which can be completed using a single setup, is the most effective method for treating SBBC.
format Online
Article
Text
id pubmed-9359036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93590362022-08-10 Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer Kang, Sang‐Won Kang, Seonghee Lee, Boram Song, Changhoon Eom, Keun‐Yong Jang, Bum‐Sup Kim, In Ah Kim, Jae‐Sung Cho, Woong Shin, Dong‐Suk Kim, Jin‐Young Chung, Jin‐Beom J Appl Clin Med Phys Radiation Oncology Physics This study is to investigate the optimal treatment option for synchronous bilateral breast cancer (SBBC) by comparing dosimetric and radiobiological parameters of intensity‐modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) plans using single and dual isocenters. Twenty patients with SBBC without lymph node involvement were selected retrospectively. Four treatment plans were generated for each patient using the Eclipse treatment planning system (Varian Medical System, Palo Alto, CA, USA) following two delivery techniques with two isocenter conditions—IMRT using a single isocenter (IMRT_Iso1), VMAT using a single isocenter (VMAT_Iso1), IMRT using dual isocenters (IMRT_Iso2), and VMAT using dual isocenters (VMAT_Iso2). A dose of 42.56 Gy in 16 fractions was prescribed for the planning target volume (PTV). All plans were calculated using the Acuros XB algorithm and a photon optimizer for a 6‐MV beam of a Vital Beam linear accelerator. PTV‐related dosimetric parameters were analyzed. Further, the homogeneity index, conformity index, and conformation number were computed to evaluate plan quality. Dosimetric parameters were also measured for the organs at risk (OARs). In addition, the equivalent uniform dose corresponding to an equivalent dose related to a reference of 2 Gy per fraction, the tumor control probability, and the normal tissue complication probability were calculated based on the dose–volume histogram to investigate the radiobiological impact on PTV and OARs. IMRT_Iso1 exhibited similar target coverage and a certain degree of dosimetric improvement in OAR sparing compared to the other techniques. It also exhibited some radiobiological improvement, albeit insignificant. Although IMRT_Iso1 significantly increased monitor unit compared to VMAT_Iso1, which is the best option in terms of delivery efficiency, there was only a 22% increase in delivery time. Therefore, in conclusion, IMRT_Iso1, the complete treatment of which can be completed using a single setup, is the most effective method for treating SBBC. John Wiley and Sons Inc. 2022-06-21 /pmc/articles/PMC9359036/ /pubmed/35727562 http://dx.doi.org/10.1002/acm2.13706 Text en © 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Kang, Sang‐Won
Kang, Seonghee
Lee, Boram
Song, Changhoon
Eom, Keun‐Yong
Jang, Bum‐Sup
Kim, In Ah
Kim, Jae‐Sung
Cho, Woong
Shin, Dong‐Suk
Kim, Jin‐Young
Chung, Jin‐Beom
Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title_full Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title_fullStr Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title_full_unstemmed Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title_short Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
title_sort evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359036/
https://www.ncbi.nlm.nih.gov/pubmed/35727562
http://dx.doi.org/10.1002/acm2.13706
work_keys_str_mv AT kangsangwon evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT kangseonghee evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT leeboram evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT songchanghoon evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT eomkeunyong evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT jangbumsup evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT kiminah evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT kimjaesung evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT chowoong evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT shindongsuk evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT kimjinyoung evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer
AT chungjinbeom evaluationofthedosimetricandradiobiologicalparametersinfourradiotherapyregimensforsynchronousbilateralbreastcancer